Gap junctions in normal and neoplastic mammary gland

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 343-349

  Locke, Darren ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast; Cancer; Connexin; Connexon; Gap junction; Intercellular communication; Lactation; Mammary; Pregnancy

Indexed keywords

GAP JUNCTION PROTEIN;

BREAST CARCINOMA; CELL COMMUNICATION; CELL DIFFERENTIATION; GAP JUNCTION; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL COMMUNICATION; FEMALE; GAP JUNCTIONS; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY; RATS;

EID: 0032431873     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<343::AID-PATH189>3.0.CO;2-X     Document Type: Review

References (94)

1. Jamieson S, Going JJ, D'Arcy R, David-George W. Expression of gap junction protein connexin26 and connexin43 in normal human breast and breast tumours. J Pathol 1998; 184: 37-43.
2. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signalling. Eur J Biochem 1996; 238: 1-27.
3. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons and intercellular communication. Annu Rev Biochem 1996; 65: 475-502.
4. White TW, Bruzzone R. Multiple connexin proteins in single intercellular channels: connexin compatibility and functional consequences. J Bioenerg Biomembr 1996; 28: 339-350.
5. Willecke K, Haubrich C. Connexin expression systems; to what extent do they reflect the situation in the animal? J Bioenerg Biomembr 1996; 28: 319-326.
6. Caspar DL, Goodenough DA, Makowski L, Phillips WC. Gap junction structures. I. Correlated electron microscopy and X-ray diffraction. J Cell Biol 1977; 74: 605-628.
7. Kumar NM, Friend DS, Gilula NB. Synthesis and assembly of human beta 1 gap junctions in BHK cells by DNA transfection with the human beta 1 cDNA. J Cell Sci 1995; 108: 3725-3734.
8. Hurtley SM, Helenius A. Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol 1989; 5: 277-307.
9. Musil LS, Goodenough DA. Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 1993; 74: 1065-1077.
10. Unwin N, Ennis P. Two configurations of a channel-forming membrane protein. Nature 1984; 307: 609-613.
11. Musil LS, Cunningham BA, Edelman GM, Goodenough DA. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol 1990; 111: 2077-2088.
12. Diez JA, Ahmed S, Evans WH. Biogenesis of liver gap junctions. In: Werner R, ed. Gap Junctions. Amsterdam: IOS Press, 1998; 130-134.
13. Epstein ML, Sheridan JD, Johnson RG. Formation of low-resistance junctions in vitro in the absence of protein synthesis and ATP production. Exp Cell Res 1977; 104: 25-30.
14. White TW, Paul DL, Goodenough DA, Bruzzone R. Functional analysis of selective interactions among rodent connexins. Mol Biol Cell 1995; 6: 459-470.
15. Perkins GA, Goodenough DA, Sosinsky GE. Structural considerations for connexon docking. In: Werner R, ed. Gap Junctions. Amsterdam: IOS Press, 1998; 13-17.
16. Rahman S, Carlile G, Evans WH. Assembly of hepatic gap junctions. Topography and distribution of connexin 32 in intracellular and plasma membranes determined using sequence-specific antibodies. J Biol Chem 1993; 268: 1260-1265.
17. Slauffer KA. The gap junction proteins beta(1)-connexin (connexin32) and beta(2)-connexin (connexin26) can form heteromeric hemichannels. J Biol Chem 1995; 270: 6768-6772.
18. Jiang JX, Goodenough DA. Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci USA 1996; 93: 1287-1291.
19. Paul DL, Yu K, Bruzzone R, Gimlich RL, Goodenough DA. Expression of a dominant negative inhibitor of intercellular communication in the early Xenopus embryo causes delamination and extrusion of cells. Development 1995; 121: 371-381.
20. Buehler LK, Stauffer K, Gilula NB, Kumar NM. Single channel behaviour of recombinant beta 2 gap junction connexons reconstituted into planar lipid bilayers. Biophys J 1995; 68: 1767-1775.
21. Dahl G, Miller T, Paul D, Voellmy R, Werner R. Expression of functional cell-cell channels from cloned rat liver gap junction complementary DNA. Science 1987; 236: 1290-1293.
22. Elfgang C, Eckert R, Lichtenberg-Fraté H, et al. Specific permeability and selective formation of gap junction channels in connexin transfected HeLa cells. J Cell Biol 1995; 129: 805-817.
23. Robinson SR, Hampson EC, Munro MN, Vaney D. Unidirectional coupling of gap junctions between neuroglia. Science 1993; 262: 1072-1074.
24. Harris AL, Bevans CG. Molecular selectivity of homomeric and heteromeric connexin channels. In: Werner R, ed. Gap Junctions. Amsterdam: IOS Press, 1998; 60-66.
25. Warner AE. Gap junctions in development - a perspective. Semin Cell Biol 1992; 3: 81-91.
26. Brissette JL, Kumar NM, Gilula NB. Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation. Proc Natl Acad Sci USA 1994; 91: 6453-6457.
27. Zhang M, Thorgeirsson S. Modulation of connexins during differentiation of oval cells into hepatocytes. Exp Cell Res 1994; 213: 37-42.
28. Yamasaki H. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional communication. Toxicol Lett 1995; 77: 55-61.
29. Mehta PP, Hotz-Wagenblatt A, Rose B, Shalloway D, Loewenstein WR. Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Membr Biol 1991; 124: 207-225.
30. Rose B, Mehta PP, Loewenstein WR. Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 1993; 14: 1073-1075.
31. Mesnil M, Krutovskikh V, Piccoli C, et al. Negative growth control of HeLa cells by connexin genes: connexin specie specificity. Cancer Res 1995; 55: 629-639.
32. Nicholson SM, Bruzzone R. Gap junctions: getting the message through. Curr Biol 1997; 7: R340-R344.
33. Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WH. Mutations of connexin43 gap junction gene in patients with heart malformations and aspects of laterality. N Engl J Med 1995; 332: 1323-1329.
34. Bergoffen J, Scherer SS, Wang S, et al. Connexin mutation in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-2042.
35. Carrasquillo MM, Zlotogora J, Barges S, Chakravarti A. Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet 1997; 6: 2163: 2172.
36. Steele EC Jr, Lyon MF, Glenister PH, Guillot PV, Church RL. Identification of a mutation in the connexin50 (Cx50) gene of the NO2 cataractous mouse mutant. In: Werner R, ed. Gap Junctions. Amsterdam: IOS Press, 1998; 289-293.
37. Risek B, Guthrie S, Kumar N, Gilula NB. Modulation of gap junction transcript and protein expression during pregnancy in the rat. J Cell Biol 1990; 110:269-282.
38. Wiesen JF, Midgely AR Jr. Expression of connexin 43 gap junction messender ribonucleic acid and protein during follicular atresia. Biol Reprod 1994; 50: 336-348.
39. Yu W, Dahl G, Werner R. The connexin43 gene is responsive to oestrogen. Proc R Soc London. Ser. B Biol Sci 1994; 225: 125-132.
40. Hendrix ME, Myatt L, Sellers S, Russell PT, Larsen WJ. Steroid hormone regulation of rat myometrial gap junction formation: effects on Cx43 levels and trafficking. Biol Reprod 1995; 52: 547-560.
41. Neuhaus IM, Dahl G, Werner R. Use of alternate promoters for tissue-specific expression of the gene coding for connexin32. Gene 1995; 158: 257-262.
42. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1980; 60: 1049-1105.
43. DeOme KB, Faulkin LJ, Bern HA, Blair PB. Development of mammary tumours from hyperplastic luminal nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959; 19: 515-520.
44. Shivers RR, McVicar LK. Gap junctions revealed by freeze-fracture electron microscopy. Microsc Res Tech 1995; 31: 437-445.
45. Pitelka DR, Hamamoto ST, Duafala JG, Nemanic MK. Cell contacts in the mouse mammary gland. I. Normal gland in postnatal development and the secretory cycle. J Cell Biol 1973; 56: 797-818.
46. Berga SE. Electrical potentials and cell-to-cell dye movement in mouse mammary gland during lactation. Am J Physiol 1984; 247: C20-C25.
47. Monaghan P, Perusinghe N, Carlile G, Evans WH. Rapid modulation of gap junction expression in mouse mammary gland during pregnancy, lactation, and involution. J Histochem Cytochem 1994; 42: 931-938.
48. Pozzi A, Risek B, Kiang DT, Gilula NB, Kumar NM. Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 1995; 220: 212-219.
49. Perez-Armendariz EM, Luna J, Aceves C, Tapia D. Connexins 26, 32 and 43 are expressed in virgin, pregnant and lactating mammary glands. Dev Growth Differ 1995; 37: 421-431.
50. Meda P, Bosco D, Giordano E, Chanson M. Junctional coupling modulated by secretagogues in two-cell pancreatic systems. In: Peracchia C, ed. Biophysics of Gap Junction Channels. Boca Raton: CRC Press, 1990; 192-208.
51. Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC. Development and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation 1994; 57: 205-214.
52. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995; 269: 234-238.
53. Yamanaka I, Kuraoka A, Inai T, Ishibashi T, Shibata Y. Changes in the phosphorylation states of connexin43 in myoepithelial cells of lactating rat mammary glands. Eur J Cell Biol 1997; 72: 166-173.
54. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267: 1831-1834.
55. Garfield RE, Blennerhassett MG, Miller SM. Control of myometrial contractility: role and regulation of gap junctions. Oxford Rer Reprod Biol 1988; 10: 436-490.
56. Young WS 3rd, Shepard E, Amico J, et al. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol 1996; 8: 847-853.
57. Radice GL, Ferreira-Cornwell MC, Robinson SD. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997; 139: 1025-1032.
58. Monaghan P, Clarke C, Perusinghe NP, Moss DW, Chen XY, Evans WH. Gap junction distribution and connexin expression in human breast. Exp Cell Res 1996; 223: 29-38.
59. Loewenstein WR, Kanno Y. Intercellular communication and tissue growth. I. Cancerous growth. J Cell Biol 1967; 33: 225-234.
60. Hotz-Wagenblatt A, Shalloway D. Gap Junctional communication and neoplastic transformation. Crit Rev Oncog 1993; 4: 541-558.
61. Yamasaki H. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional communication. Toxicol Lett 1995; 77: 55-61.
62. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lau AF. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 1997; 8: 1015-1027.
63. Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ, Yamasaki H. Gap-junctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. Cancer Res 1989; 49: 699-705.
64. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 1992; 51: 522-529.
65. Grossman HB, Liebert M, Lee IW, Lee SW. Decreased connexin expression and intercellular communication in human bladder cancer cells. Cancer Res 1994; 54: 3062-3065.
66. Sato K, Gratas C, Lampe J, et al. Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas. J Neuropathol Exp Neurol 1997; 56: 835-839.
67. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of gap junctions in tumorigenesis: transfection of tumour cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 1991; 88: 10701-10705.
68. Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996; 7: 861-870.
69. Zhu D, Kidder GM, Caveney S, Naus CC. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci USA 1992; 89: 10218-10221.
70. Goldberg GS, Martyn KD, Lau AF. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol Carcinogen 1994; 11: 106-114.
71. Swenson KI, Piwnica-Worms H, McNamee H, Paul DL. Tyrosine phosphorylation of the gap junction protein connexin43 is required for the pp60v-src-induced inhibition of communication. Cell Regul 1990; 1: 989-1002.
72. Clark GJ, Der CJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 1995; 35: 133-144.
73. Gusterson BA. Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression. Eur J Cancer 1992; 28: 263-267.
74. Brissette JL, Kumar NM, Gilula NB, Dotto GP. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins. Mol Cell Biol 1991; 11: 5364-5371.
75. Jou YS, Layhe B, Matesic DF, et al. Inhibition of gap junctional intercellular communication and malignant transformation of rat liver epithelial cells by neu oncogene. Carcinogenesis 1995; 16: 311-317.
76. Kanno Y, Sasaki Y, Shiba Y, Yoshida-Noro C, Takeichi M. Monoclonal antibody ECCD-1 inhibits intercellular communication in teratocarcinoma PCC3 cells. Exp Cell Res 1984; 152: 270-274.
77. Jansen LA, Mesnil M, Jongen WM. Inhibition of gap junctional intercellular communication and delocalization of the cell adhesion molecule E-cadherin by tumor promoters. Carcinogenesis 1996; 17: 1527-1531.
78. Wang Y, Rose B. An inhibition of gap-junctional communication by cadherins. J Cell Sci 1997; 110: 301-309.
79. Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 1995; 169: 511-519.
80. Perr AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 101-193.
81. Behrens J, Mareel MM, Van-Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-2447.
82. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP, Byers SW. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ 1991; 2: 365-372.
83. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 1995; 11: 1319-1326.
84. Fentiman IS, Hurst J, Ceriani RL, Taylor-Papadimitriou J. Junctional intercellular communication pattern of cultured human breast cancer cells. Cancer Res 1979; 39: 4739-4743.
85. Eldridge SR, Martens TW, Sattler CA, Gould MN. Association of decreased intercellular communication with the immortal but not the tumorigenic phenotype in human mammary epithelial cells. Cancer Res 1989; 49: 4326-4331.
86. Lee SW, Tomasetto C, Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proe Natl Acad Sci USA 1991; 88: 2825-2829.
87. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 1992; 118: 1213-1221.
88. Tomasetto C, Neveu MJ, Daley J, Horan PK, Sager R. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J Cell Biol 1993; 122: 157-167.
89. Sawey MJ, Goldschmidt MH, Risek B, Gilula NB, Lo CW. Perturbation in connexin 43 and connexin 26 gap junction expression in mouse skin hyperplasia and neoplasia. Mol Carcinogen 1996; 17: 49-61.
90. Kambayashi Y, Oyamada Y, Mori M, Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumour progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 1995; 16: 1287-1297.
91. Xing S, Smanik PA, Oglesbee MJ, et al. Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes. Endocrinology 1996; 137: 1512-1519.
92. Guinan EC, Smith BR, Davies PF, Pober JS. Cytoplasmic transfer between endothelium and lymphocytes: quantification by flow cytometry. Am J Pathol 1988; 132: 406-409.
93. El-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumour cells and vascular endothelium. J Cell Biol 1991; 115: 1375-1382.
94. Brauner T, Hulser D. Tumour cell invasion and gap junctional communication. II. Normal and malignant cells confronted in multicell spheroids. Invasion Metastasis 1990; 10: 31-48.